As recently published by Jang and colleagues, endogenous hepatic plasmalogens appear to be involved in fatty acid metabolism and inhibit steatosis and NASH progression through PPARα-dependent signaling [41]. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.